Provident Healthcare Capital, an affiliated Company of Provident Healthcare Partners, is a direct investment fund dedicated to helping healthcare services companies achieve their growth objectives. Through a direct investment fund, which includes the principals of Provident as well as institutional and high-net worth investors, we provide early-stage funding as well as growth and buyout capital for more mature operating companies.
Combining Provident’s healthcare experience and expertise with the fund’s capital and resources, PH Capital is a valued investor for healthcare companies seeking a unique capital partner. We encourage you to contact us about any potential opportunity that may be of interest.
BioDirection, a medical device company developing novel point-of-care products for the diagnosis of concussion and other traumatic brain injury (TBI), has closed over $4 million in Series B financing. Provident Healthcare Capital made a direct investment in BioDirection and Provident Healthcare Partners has been engaged as exclusive financial advisor to BioDirection.